Access Course

 

Immune-Related Adverse Events in Oncology Patients: Would You Know?Apply best practices to monitoring for, diagnose, and manage potential irAEs in patient with cancer receiving ICIs

 

This activity is intended for hematology/oncology specialists, emergency medicine physicians, and primary care physicians.

 

The goal of this activity is to build physician confidence in monitoring for, diagnosing, and managing immune-related adverse events (irAEs) that may occur in patients receiving immune checkpoint inhibitors (ICIs).

 

Approximate Time to Complete: 1 hour

 

Credit Available: Jan. 16, 2019 - Jan. 16, 2020

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Demonstrate improved performance associated with ordering appropriate tests to monitor for immune-related adverse events (irAEs) that may occur in patients receiving immune checkpoint inhibitors (ICIs)
  • Demonstrate improved performance associated with diagnosing irAEs in patients receiving ICIs progression
  • Demonstrate improved performance associated with selecting appropriate management of irAEs in patients receiving ICIs
American Board of Internal Medicine
ABIM MOC Part 2 Credits: 1.00
Accreditation Council for Continuing Medical Education (MD/DO)
AMA PRA Category 1 Credit(s)™: 1.00